Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H31Cl2NO3 |
Molecular Weight | 440.403 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C=C(OC(=O)N(CCCl)CCCl)C=C4
InChI
InChIKey=FRPJXPJMRWBBIH-RBRWEJTLSA-N
InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1
Molecular Formula | C23H31Cl2NO3 |
Molecular Weight | 440.403 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:03 UTC 2023
by
admin
on
Fri Dec 15 15:04:03 UTC 2023
|
Record UNII |
35LT29625A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000007246
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
WHO-ATC |
L01XX11
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
NDF-RT |
N0000175558
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
LIVERTOX |
373
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
NDF-RT |
N0000007246
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
NCI_THESAURUS |
C697
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
NCI_THESAURUS |
C25974
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
NDF-RT |
N0000007659
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
WHO-VATC |
QL01XX11
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
||
|
NDF-RT |
N0000000236
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB07246MIG
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
D004961
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
m5031
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | Merck Index | ||
|
ESTRAMUSTINE
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
4089
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | RxNorm | ||
|
4868
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
100000082381
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
DB01196
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
DTXSID8046458
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
C479
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
CHEMBL1575
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
259331
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
35LT29625A
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
221-076-3
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
2998-57-4
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
1065
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
2877
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
89201
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY | |||
|
35LT29625A
Created by
admin on Fri Dec 15 15:04:03 UTC 2023 , Edited by admin on Fri Dec 15 15:04:03 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
Metabolite produced by hydrolysis. Estramustine,s primary mechanism of antineoplastic action is inhibition of mitosis.
PLASMA
|
||
|
PRODRUG -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |